Skip to main content

Table 4 Antimicrobial susceptibility of 309 pneumococcal isolates obtained from nasopharyngeal and oropharyngeal swabs collected from 375 parents of children under 5 years of age in Western Kenya, by antiobiotic.

From: High Streptococcus pneumoniae colonization prevalence among HIV-infected Kenyan parents in the year before pneumococcal conjugate vaccine introduction

Antibiotic

Susceptible

Intermediate

Resistant

 

Break-point a

N (%)

Break-point

N (%)

Break-point

N (%)

Penicillin

≤0.06

60 (19.4)

0.12-1

249 (78.6)

≥2

6 (1.9)

Chloramphenicol

≤4

305 (98.7)

n/a

n/a

≥8

4 (1.3)

Levofloxacin

≤2

312 (100)

4

0

≥8

0

Erythromycin

≤0.25

305 (98.7)

0.5

1 (0.3)

≥1

3 (1.0)

Ceftriaxone

≤1

309 (100)

2

0

≥4

0

Tetracycline

≤2

232 (75.3)

4

12 (3.9)

≥8

64 (20.8)

Cotrimoxazole

≤0.5/9.5

3 (1.0)

1/19–2/38

13 (4.2)

≥4/76

291 (94.8)

Clindamycin

≤0.25

308 (99.7)

0.5

0

≥1

1(0.3)

  1. aBreakpoints defined using Clinical and Laboratory Standards Institute (CLSI) guidelines 2007 for penicillin and 2012 for all other antibiotics
  2. n/a not applicable